Literature DB >> 2494292

Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components.

K Iida1, M B Whitlow, V Nussenzweig.   

Abstract

We studied the effect of complement on two life cycle stages of the protozoan parasite Trypanosoma cruzi: epimastigotes, found in the insect vector, and amastigotes, found in the mammalian host. We found that while both stages activate vigorously the alternative pathway, only epimastigotes are destroyed. The amounts of C3 and C5b-7 deposited on the amastigotes were similar to those bound to the much larger epimastigotes. Binding of C9 to amastigotes was four to six times less than binding to epimastigotes, resulting in a lower C9/C5b-7 ratio. Although a fairly large amount of C9 bound stably to amastigotes, no functional channels were formed as measured by release of incorporated 86Rb. The bound C9 had the characteristic properties of poly-C9, that is, it expressed a neo-antigen unique to poly-C9, and migrated in SDS-PAGE with an apparent Mr greater than 10(5). The poly-C9 was removed from the surface of amastigotes by treatment with trypsin, indicating that it was not inserted in the lipid bilayer. Modification of amastigote surface by pronase treatment rendered the parasites susceptible to complement attack. These results suggest that amastigotes have a surface protein that binds to the C5b-9 complex and inhibits membrane insertion, thus protecting the parasites from complement-mediated lysis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494292      PMCID: PMC2189257          DOI: 10.1084/jem.169.3.881

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Transmembrane channel formation by complement: functional analysis of the number of C5b6, C7, C8, and C9 molecules required for a single channel.

Authors:  L E Ramm; M B Whitlow; M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

2.  The ninth component of human complement: purification and physicochemical characterization.

Authors:  G Biesecker; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

3.  Circular polymerization of the ninth component of complement. Ring closure of the tubular complex confers resistance to detergent dissociation and to proteolytic degradation.

Authors:  E R Podack; J Tschopp
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

4.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

5.  The reaction mechanism of human C5 in immune hemolysis.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

6.  Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages.

Authors:  T L Kipnis; J R David; C A Alper; A Sher; W D da Silva
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

7.  Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells.

Authors:  V Ley; N W Andrews; E S Robbins; V Nussenzweig
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

8.  Studies on the selective lysis and purification of Trypanosoma cruzi.

Authors:  N Nogueira; C Bianco; Z Cohn
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

9.  Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan.

Authors:  S M Puentes; D L Sacks; R P da Silva; K A Joiner
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death.

Authors:  G R Harriman; E R Podack; A I Braude; L C Corbeil; A F Esser; J G Curd
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

View more
  18 in total

1.  Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.

Authors:  Meenu Mishra; Matthew S Byrd; Susan Sergeant; Abul K Azad; Matthew R Parsek; Linda McPhail; Larry S Schlesinger; Daniel J Wozniak
Journal:  Cell Microbiol       Date:  2011-11-10       Impact factor: 3.715

2.  The major surface glycoprotein of Trypanosoma cruzi amastigotes are ligands of the human serum mannose-binding protein.

Authors:  S J Kahn; M Wleklinski; R A Ezekowitz; D Coder; A Aruffo; A Farr
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 3.  Complement evasion by parasites: search for "Achilles' heel".

Authors:  Z Fishelson
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 4.  Carbohydrate immunity in American trypanosomiasis.

Authors:  L R Travassos; I C Almeida
Journal:  Springer Semin Immunopathol       Date:  1993

Review 5.  Complement resistance in microbes.

Authors:  M C Moffitt; M M Frank
Journal:  Springer Semin Immunopathol       Date:  1994

Review 6.  Complement-related proteins in pathogenic organisms.

Authors:  Z Fishelson
Journal:  Springer Semin Immunopathol       Date:  1994

7.  Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa.

Authors:  Meenu Mishra; Adam Ressler; Larry S Schlesinger; Daniel J Wozniak
Journal:  Infect Immun       Date:  2015-05-11       Impact factor: 3.441

8.  Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor.

Authors:  S Kahn; M Wleklinski; A Aruffo; A Farr; D Coder; M Kahn
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

9.  Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.

Authors:  Claudia Hammerschmidt; Arno Koenigs; Corinna Siegel; Teresia Hallström; Christine Skerka; Reinhard Wallich; Peter F Zipfel; Peter Kraiczy
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

10.  Improved method for in vitro secondary amastigogenesis of Trypanosoma cruzi: morphometrical and molecular analysis of intermediate developmental forms.

Authors:  L A Hernández-Osorio; C Márquez-Dueñas; L E Florencio-Martínez; G Ballesteros-Rodea; S Martínez-Calvillo; R G Manning-Cela
Journal:  J Biomed Biotechnol       Date:  2009-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.